Roberto Biassoni

Title: The Innovative Contributions of Roberto Biassoni

Introduction

Roberto Biassoni is a prominent inventor based in Genoa, Italy, known for his significant contributions to the field of immunology. With a total of six patents to his name, Biassoni has made remarkable advancements in understanding natural killer (NK) cells and their role in human immunity.

Latest Patents

Biassoni's latest patents include groundbreaking inventions such as the "Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify the same." This invention introduces a novel compound termed NKp30, which is selectively expressed by all mature NK cells and acts as an activatory receptor in human natural cytotoxicity. Additionally, he has developed methods of diagnosis and treatment by binding p75/AIRM1, which is expressed on myeloid cells. This discovery is particularly useful in monitoring cellular proliferation and determining the proliferative states of cells, especially in diseases like chronic myeloid leukemia.

Career Highlights

Throughout his career, Biassoni has worked with esteemed institutions such as the University of Genoa and Innate Pharma S.A.S. His research has significantly impacted the understanding of immune responses and therapeutic approaches in oncology.

Collaborations

Biassoni has collaborated with notable colleagues, including Alessandro Moretta and Cristina Bottino, further enhancing the depth and breadth of his research contributions.

Conclusion

Roberto Biassoni's innovative work in immunology and his numerous patents underscore his vital role in advancing medical science. His contributions continue to influence the field and pave the way for future research and therapeutic developments.